These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 18812504)

  • 21. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
    Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
    PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis.
    Evans TJ
    Future Microbiol; 2015; 10(2):231-9. PubMed ID: 25689535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. McKay agar enables routine quantification of the 'Streptococcus milleri' group in cystic fibrosis patients.
    Sibley CD; Grinwis ME; Field TR; Parkins MD; Norgaard JC; Gregson DB; Rabin HR; Surette MG
    J Med Microbiol; 2010 May; 59(Pt 5):534-540. PubMed ID: 20093379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.
    Hogardt M; Heesemann J
    Curr Top Microbiol Immunol; 2013; 358():91-118. PubMed ID: 22311171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling.
    Rogers GB; Carroll MP; Serisier DJ; Hockey PM; Jones G; Bruce KD
    J Clin Microbiol; 2004 Nov; 42(11):5176-83. PubMed ID: 15528712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cystic fibrosis airway microbiome.
    Rabin HR; Surette MG
    Curr Opin Pulm Med; 2012 Nov; 18(6):622-7. PubMed ID: 22965275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of diversity within the genus Pseudomonas in the lungs of cystic fibrosis patients.
    Spasenovski T; Carroll MP; Payne MS; Bruce KD
    Diagn Microbiol Infect Dis; 2009 Mar; 63(3):261-7. PubMed ID: 19216939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.
    Taccetti G; Campana S; Festini F; Mascherini M; Döring G
    Eur Respir J; 2005 Sep; 26(3):458-61. PubMed ID: 16135728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evolving dynamics of the microbial community in the cystic fibrosis lung.
    McGuigan L; Callaghan M
    Environ Microbiol; 2015 Jan; 17(1):16-28. PubMed ID: 24801013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis.
    Rogers GB; Carroll MP; Serisier DJ; Hockey PM; Jones G; Kehagia V; Connett GJ; Bruce KD
    J Clin Microbiol; 2006 Jul; 44(7):2601-4. PubMed ID: 16825392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum.
    Turner KH; Wessel AK; Palmer GC; Murray JL; Whiteley M
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4110-5. PubMed ID: 25775563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
    Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
    Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation.
    Drenkard E; Ausubel FM
    Nature; 2002 Apr; 416(6882):740-3. PubMed ID: 11961556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of 16S rRNA variable regions provides a detailed analysis of bacterial community dynamics in the lungs of cystic fibrosis patients.
    Doud MS; Light M; Gonzalez G; Narasimhan G; Mathee K
    Hum Genomics; 2010 Feb; 4(3):147-69. PubMed ID: 20368138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Pseudomonas aeruginosa isolated from chronically infected children with cystic fibrosis in India.
    Agarwal G; Kapil A; Kabra SK; Das BK; Dwivedi SN
    BMC Microbiol; 2005 Jul; 5():43. PubMed ID: 16033658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN; Ratjen F
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biogeochemical forces shape the composition and physiology of polymicrobial communities in the cystic fibrosis lung.
    Quinn RA; Lim YW; Maughan H; Conrad D; Rohwer F; Whiteson KL
    mBio; 2014 Mar; 5(2):e00956-13. PubMed ID: 24643867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic therapy in cystic fibrosis. Evaluation of efficacy.
    Levy J
    Chest; 1988 Aug; 94(2 Suppl):150S-156S. PubMed ID: 3135160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.